Advertisement
Screener

ONYX PHARMACEUTICALS INC Depreciation

ONYX PHARMACEUTICALS INC Depreciation

ONYX PHARMACEUTICALS INC reported Depreciation of $4.30 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2013-08-09

  • ONYX PHARMACEUTICALS INC depreciation for the quarter ending 2013-06-30 was $2.31M, a 89.57% increase year-over-year.
  • ONYX PHARMACEUTICALS INC depreciation for the quarter ending 2013-03-31 was $1.99M, a 56.12% increase year-over-year.
  • ONYX PHARMACEUTICALS INC depreciation for the quarter ending 2012-06-30 was $1.22M.
  • ONYX PHARMACEUTICALS INC depreciation for the quarter ending 2012-03-31 was $1.27M.
  • ONYX PHARMACEUTICALS INC depreciation for fiscal 2012 was $5.17M, a 5.27% decline from fiscal 2011.
  • ONYX PHARMACEUTICALS INC depreciation for fiscal 2011 was $5.46M, a 50.04% increase from fiscal 2010.
  • ONYX PHARMACEUTICALS INC depreciation for fiscal 2010 was $3.64M, a 127.56% increase from fiscal 2009.
  • ONYX PHARMACEUTICALS INC depreciation for fiscal 2009 was $1.60M.
Period endDepreciation 3 monthDepreciation 6 monthDepreciation 12 monthDepreciation 12 month as first filed
2013-06-30$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$4.30M
10-Q · filed 2013-08-09
2013-03-31$1.99M
10-Q · filed 2013-05-08
2012-12-31$5.17M
10-K · filed 2013-02-28
2012-06-30$1.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$2.49M
10-Q · filed 2013-08-09
2012-03-31$1.27M
10-Q · filed 2013-05-08
2011-12-31$5.46M
10-K · filed 2013-02-28
$5.50M
10-K · filed 2012-02-27
2010-12-31$3.64M
10-K · filed 2013-02-28
$3.60M
10-K · filed 2012-02-27
2009-12-31$1.60M
10-K · filed 2012-02-27